Implantable Drug Delivery Devices Gain Precedence over Other Drug Delivery Devices

Implantable drug delivery devices are drug eluting devices implanted at targeted sites for therapeutic applications. The global implantable drug delivery devices market was valued at USD 11.6 billion in 2011 and is expected to grow at a CAGR of 8.8% from 2012 to 2018 to reach an estimated value of USD 21.1 billion in 2018.


Albany, NY -- (SBWIRE) -- 03/29/2016 -- The global implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs to the affected area. These implantable drug delivery devices are categorized into six product types and this report estimates their market in terms of USD million, for the period 2012 – 2018, keeping 2011 as the base year.

Read Complete Report @

The market is segmented on the basis of product types into implantable infusion pumps, brachytherapy seeds, contraceptive implants, drug eluting stents, bio-absorbable stents and intraocular drug delivery implants. The market for all these product segments is provided in this report for four major geographic regions namely North America, Europe, Asia and the rest of the world regions (RoW). The market is segmented on the basis of technology into biodegradable and non-biodegradable implant technology and on the basis of applications into oncology, cardiovascular, contraceptive, ophthalmology and others (diabetes, inflammatory conditions).

Read Full Table of Content @

A competitive landscape, mapping all the market players and their respective market shares for 2011 are provided in this report along with some major business strategies adopted by these players to accentuate market shares. A chapter on recommendations for existing and new entrants is also provided.

Some of the major players profiled in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

The global implantable drug delivery devices market is segmented into the following categories:

Implantable Drug Delivery Devices Market by Product Types

Implantable coronary drug eluting stents
Implantable bio-absorbable stents
Implantable contraceptive drug delivery devices
Implantable intraocular drug delivery devices
Implantable brachytherapy seeds
Implantable drug infusion pumps

Inquiry on this report @

Implantable Drug Delivery Devices Market by Technology

Biodegradable implantable drug delivery device technology
Non-biodegradable implantable drug delivery device technology

Implantable Drug Delivery Devices Market by Applications

Birth control/contraception
Other (diabetes, chronic pain causing diseases)

Request a Free Sample Copy of the Report @

Implantable Drug Delivery Devices Market by Geography

North America
Rest of the world (RoW)

MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.

More Research Reports Database @